Further mechanisms of PARP inhibitor resistance in BRCA-mutated cancer cells include decreased PARP1 trapping by PARP1 mutation [20] and downregulation of PARG [21], and replication fork stabilization by loss of EZH2 and PTIP [22]. The gene discussed is PARG; the disease is cancer.